Pediatric T-cell leukemia

Common Name(s)

Pediatric T-cell leukemia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pediatric T-cell leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Pediatric T-cell leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Pediatric T-cell leukemia" returned 40 free, full-text research articles on human participants. First 3 results:

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
 

Author(s): Yunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, Andrew P Stubbs, Eric M Vroegindeweij, Willem K Smits, Ronald van Marion, Winand N M Dinjens, Martin Horstmann, Roland P Kuiper, Rogier C Buijsman, Guido J R Zaman, Peter J van der Spek, Rob Pieters, Jules P P Meijerink

Journal:

 

Pediatric acute lymphoblastic leukemia (ALL) is the most common childhood cancer and the leading cause of cancer-related mortality in children. T cell ALL (T-ALL) represents about 15% of pediatric ALL cases and is considered a high-risk disease. T-ALL is often associated with resistance ...

Last Updated: 20 Dec 2016

Go To URL
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.
 

Author(s): Barbara L Asselin, Meenakshi Devidas, Lu Chen, Vivian I Franco, Jeanette Pullen, Michael J Borowitz, Robert E Hutchison, Yaddanapudi Ravindranath, Saro H Armenian, Bruce M Camitta, Steven E Lipshultz

Journal: J. Clin. Oncol.. 2016 Mar;34(8):854-62.

 

To determine the oncologic efficacy, cardioprotective effectiveness, and safety of dexrazoxane added to chemotherapy that included a cumulative doxorubicin dose of 360 mg/m(2) to treat children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic ...

Last Updated: 3 Mar 2016

Go To URL
The origin of relapse in pediatric T-cell acute lymphoblastic leukemia.
 

Author(s): Carmen Vicente, Jan Cools

Journal: Haematologica. 2015 Nov;100(11):1373-5.

 

Last Updated: 2 Nov 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Pediatric T-cell leukemia" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
 

Status: Recruiting

Condition Summary: Acute Lymphoblastic Leukemia; Lymphoma, Non-Hodgkin's; Leukemia, T-Cell; Leukemia, B-Cell

 

Last Updated: 30 Mar 2017

Go to URL

Last Updated: 12 Jun 2017

Go to URL
A Phase 1 Study of CD22 CAR T-Cell Immunotherapy for CD22+ Leukemia
 

Status: Recruiting

Condition Summary: Leukemia

 

Last Updated: 10 Aug 2017

Go to URL